Skip to main content

Table 3 Prognostic factors for overall survival (OS)

From: Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

 

Univariate analysis

Multivariate analysis

p-value

p-value

Hazard Ratio

95% Confidence Interval

regimen

0.661

0.320

0.622

0.245 - 1.584

gender

0.043

0.439

0.558

0.128 - 2.443

age

0.256

0.056

1.115

0.997 - 1.248

isotype

0.264

0.160

1.558

0.840 - 2.891

ISS

0.002

0.006

4.323

1.508 - 12.397

Post-induction CR/nCR

0.059

0.291

0.395

0.070 - 2.216

post-induction ≥ VGPR

0.220

0.480

1.922

0.314 - 11.772

Post-ASCT CR/nCR

0.004

0.045

0.138

0.020 - 0.958

Post-ASCT VGPR

0.001

0.836

1.278

0.124 - 13.153